10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 10-Q

 

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2014

Or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-34942

 

 

 

LOGO

Inphi Corporation

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   77-0557980

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

2953 Bunker Hill Lane, Suite 300,

Santa Clara, California 95054

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (408) 217-7300

 

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in 12b-2 of the Exchange Act).    Yes  ¨    No  x

The total number of shares outstanding of the Registrant’s common stock, $0.001 par value per share, as of May 1, 2014 was 31,312,009.

 

 

 


Table of Contents

INPHI CORPORATION

QUARTERLY REPORT ON FORM 10-Q

FOR THE THREE MONTHS ENDED MARCH 31, 2014

TABLE OF CONTENTS

 

         Page  

PART I. FINANCIAL INFORMATION

     2   
Item 1..  

Financial Statements

     2   
 

Unaudited Condensed Consolidated Balance Sheets at March 31, 2014 and December 31, 2013

     2   
 

Unaudited Condensed Consolidated Statements of Income for the Three Months Ended March 31, 2014 and 2013

     3   
 

Unaudited Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March  31, 2014 and 2013

     4   
 

Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2014 and 2013

     5   
 

Notes to Unaudited Condensed Consolidated Financial Statements

     6   
Item 2.  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     17   
Item 3.  

Quantitative and Qualitative Disclosures about Market Risk

     22   
Item 4.  

Controls and Procedures

     23   

PART II. OTHER INFORMATION

     23   
Item 1.  

Legal Proceedings

     23   
Item 1A.  

Risk Factors

     23   
Item 6.  

Exhibits

     24   


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

INPHI CORPORATION

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

 

     March 31,
2014
    December 31,
2013
 

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 27,834      $ 31,667   

Investments in marketable securities

     89,159        90,890   

Accounts receivable, net

     18,057        13,073   

Inventories

     7,205        6,767   

Deferred tax assets

     1,099        1,099   

Income tax receivable

     198        240   

Prepaid expenses and other current assets

     3,553        2,361   
  

 

 

   

 

 

 

Total current assets

     147,105        146,097   

Property and equipment, net

     24,595        22,460   

Goodwill

     5,875        5,875   

Deferred tax charge

     3,965        4,200   

Other assets, net

     4,335        3,710   
  

 

 

   

 

 

 

Total assets

   $ 185,875      $ 182,342   
  

 

 

   

 

 

 

Liabilities and Stockholders’ Equity

    

Current liabilities:

    

Accounts payable

   $ 8,580      $ 7,280   

Deferred revenue

     1,500        1,686   

Accrued employee expenses

     3,156        4,626   

Other accrued expenses

     1,822        1,611   

Other current liabilities

     1,894        1,881   
  

 

 

   

 

 

 

Total current liabilities

     16,952        17,084   

Other long-term liabilities

     6,036        5,865   
  

 

 

   

 

 

 

Total liabilities

     22,988        22,949   
  

 

 

   

 

 

 

Commitments and contingencies (Note 13)

    

Stockholders’ equity:

    

Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued

     —          —     

Common stock, $0.001 par value; 500,000,000 shares authorized; 31,126,706 and 30,244,439 issued and outstanding at March 31, 2014 and December 31, 2013, respectively

     31        30   

Additional paid-in capital

     229,445        225,007   

Accumulated deficit

     (67,577     (66,582

Accumulated other comprehensive income

     988        938   
  

 

 

   

 

 

 

Total stockholders’ equity

     162,887        159,393   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 185,875      $ 182,342   
  

 

 

   

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2


Table of Contents

INPHI CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in thousands, except share and per share amounts)

 

     Three Months Ended March 31,  
     2014     2013  

Revenue

   $ 31,189      $ 22,584   

Cost of revenue

     11,063        8,292   
  

 

 

   

 

 

 

Gross profit

     20,126        14,292   
  

 

 

   

 

 

 

Operating expense:

    

Research and development

     13,739        11,598   

Sales and marketing

     3,950        3,947   

General and administrative

     3,065        3,155   
  

 

 

   

 

 

 

Total operating expense

     20,754        18,700   
  

 

 

   

 

 

 

Loss from operations

     (628     (4,408

Other income

     160        213   
  

 

 

   

 

 

 

Loss before income taxes

     (468     (4,195

Provision for income taxes

     527        3,476   
  

 

 

   

 

 

 

Net loss

   $ (995   $ (7,671
  

 

 

   

 

 

 

Earnings per share:

    

Basic

   $ (0.03   $ (0.27
  

 

 

   

 

 

 

Diluted

   $ (0.03   $ (0.27
  

 

 

   

 

 

 

Weighted-average shares used in computing earnings per share:

    

Basic

     30,697,808        28,933,105   

Diluted

     30,697,808        28,933,105   

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3


Table of Contents

INPHI CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands)

 

     Three Months Ended March 31,  
     2014     2013  

Net loss

   $ (995   $ (7,671

Other comprehensive income (loss):

    

Available for sale investments:

    

Change in unrealized gain, net of $0 tax

     50        —     

Realized gain reclassified into earnings, net of $0 tax

     —          (13
  

 

 

   

 

 

 

Comprehensive loss

   $ (945   $ (7,684
  

 

 

   

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4


Table of Contents

INPHI CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

     Three Months Ended March 31,  
     2014     2013  

Cash flows from operating activities

    

Net loss

   $ (995   $ (7,671

Adjustments to reconcile net loss to net cash provided by operating activities:

    

Depreciation and amortization

     2,357        1,684   

Stock-based compensation

     4,506        4,026   

Deferred income taxes and deferred tax charge

     213        697   

Excess tax benefit related to stock-based compensation

     —          (1,998

Amortization of premiums on marketable securities

     228        269   

Other noncash items

     —          (13

Changes in assets and liabilities:

    

Accounts receivable

     (4,984     1,762   

Inventories

     (438     (107

Prepaid expenses and other assets

     (1,782     9   

Income tax payable/receivable

     337        2,874   

Accounts payable

     34        154   

Accrued expenses

     (1,329     (1,059

Deferred revenue

     (186     333   

Other liabilities

     (89     137   
  

 

 

   

 

 

 

Net cash provided by (used in) operating activities

     (2,128     1,097   
  

 

 

   

 

 

 

Cash flows from investing activities

    

Purchases of property and equipment

     (3,156     (3,745

Purchases of marketable securities

     (16,713     (11,181

Sales and maturities of marketable securities

     18,231        10,564   
  

 

 

   

 

 

 

Net cash used in investing activities

     (1,638     (4,362
  

 

 

   

 

 

 

Cash flows from financing activities

    

Proceeds from exercise of stock options

     1,231        363   

Excess tax benefit related to stock-based compensation

     —          1,998   

Proceeds from employee stock purchase plan

     1,303        989   

Minimum tax withholding paid on behalf of employees for restricted stock units

     (2,601     (510
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     (67     2,840   
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     (3,833     (425

Cash and cash equivalents at beginning of period

     31,667        30,161   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 27,834      $ 29,736   
  

 

 

   

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5


Table of Contents

Inphi Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

(Dollars in thousands except share and per share amounts)

1. Organization and Basis of Presentation

Inphi Corporation (the “Company”), a Delaware corporation, was incorporated in November 2000. The Company is a fabless provider of high-speed analog and mixed signal semiconductor solutions for the communications, data center and computing markets. The Company’s semiconductor solutions are designed to address bandwidth bottlenecks in networks, maximize throughput and minimize latency in computing environments and enable the rollout of next generation communications, data center and computing infrastructures. In addition, the semiconductor solutions provide a vital high-speed interface between analog signals and digital information in high-performance systems such as telecommunications transport systems, enterprise networking equipment, data centers and enterprise servers, storage platforms, test and measurement equipment and military systems.

The interim unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), for interim financial information and with the instructions to Securities and Exchange Commission (“SEC”), Form 10-Q and Article 10 of SEC Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the year ended December 31, 2013, included in the Company’s Annual Report on Form 10-K filed with the SEC on March 5, 2014.

The interim condensed consolidated financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to state fairly the Company’s consolidated financial position at March 31, 2014, and its consolidated results of operations and cash flows for the three months ended March 31, 2014 and 2013. The results of operations for the three months ended March 31, 2014 are not necessarily indicative of the results to be expected for future quarters or the full year.

2. Recent Accounting Pronouncements

In January 2014, the Company adopted the guidance on thePresentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” The guidance provides that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The assessment of whether a deferred tax asset is available is based on the unrecognized tax benefit and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date. The amendments in this update do not require new recurring disclosures. The adoption of this guidance has no impact on the Company’s financial statements.

3. Investments

The following table summarizes the investments by investment category:

 

     March 31, 2014      December 31, 2013  
     Cost      Fair Value      Cost      Fair Value  

Available-for-sale securities:

           

U.S. treasury securities

   $ 21,676       $ 21,689       $ 25,061       $ 25,072   

Municipal bonds

     33,796         33,901         34,912         34,983   

Corporate notes/bonds

     31,537         31,635         28,565         28,648   

Certificate of deposit

     1,500         1,500         1,500         1,501   

Asset backed securities

     434         434         685         686   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total investments

   $ 88,943       $ 89,159       $ 90,723       $ 90,890   
  

 

 

    

 

 

    

 

 

    

 

 

 

As of March 31, 2014, we had 13 investments that were in an unrealized loss position. The gross unrealized losses on these investments at March 31, 2014 of $50 were determined to be temporary in nature. The Company reviews the investments to identify

 

6


Table of Contents

Inphi Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

(Dollars in thousands except share and per share amounts)

 

and evaluate investments that have an indication of possible other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include the length of time and extent to which fair value has been less than the cost basis, the financial condition and near-term prospects of the investee, and the intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value.

The realized gain related to the Company’s available-for-sale investment, which were reclassified from other comprehensive income, was included in other income in the consolidated statements of income.

The contractual maturities of available-for-sale securities at March 31, 2014 are presented in the following table:

 

     Cost      Fair Value  

Due in one year or less

   $ 34,094       $ 34,165   

Due between one and five years

     54,849         54,994   
  

 

 

    

 

 

 
   $ 88,943       $ 89,159   
  

 

 

    

 

 

 

4. Inventories

Inventories consist of the following:

 

     March 31,
2014
     December 31,
2013
 

Raw materials

   $ 767       $ 670   

Work in process

     2,012         2,001   

Finished goods

     4,426         4,096   
  

 

 

    

 

 

 
   $ 7,205       $ 6,767   
  

 

 

    

 

 

 

Finished goods held by distributors were $490 and $543 as of March 31, 2014 and December 31, 2013, respectively.

5. Property and Equipment, net

Property and equipment consist of the following:

 

     March 31,
2014
    December 31,
2013
 

Laboratory and production equipment

   $ 37,769      $ 34,443   

Office, software and computer equipment

     9,388        8,649   

Furniture and fixtures

     834        834   

Leasehold improvements

     3,951        3,952   
  

 

 

   

 

 

 
     51,942        47,878   

Less accumulated depreciation

     (27,347     (25,418
  

 

 

   

 

 

 
   $ 24,595      $ 22,460   
  

 

 

   

 

 

 

Depreciation and amortization expense of property and equipment for the three months ended March 31, 2014 and 2013 was $2,357 and $1,684, respectively.

As of March 31, 2014 and December 31, 2013, computer software costs included in property and equipment were $3,033 and $2,815, respectively. Amortization expense of capitalized computer software costs was $103 and $66 for the three months ended March 31, 2014 and 2013, respectively.

 

7


Table of Contents

Inphi Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

(Dollars in thousands except share and per share amounts)

 

6. Product Warranty Obligation

As of March 31, 2014 and December 31, 2013, the product warranty liability was $40. There was no movement in product warranty liability during the three months ended March 31, 2014 and 2013.

7. Other long-term liabilities

Other long-term liabilities consist of the following:

 

     March 31,
2014
     December 31,
2013
 

Deferred rent

   $ 1,368       $ 1,471   

Income tax payable

     3,569         3,295   

Deferred tax liabilities

     1,099         1,099   
  

 

 

    

 

 

 
   $ 6,036       $ 5,865   
  

 

 

    

 

 

 

8. Income Taxes

The Company normally determines its interim provision using an estimated single annual effective tax rate for all tax jurisdictions. ASC 740 provides that when an entity operates in a jurisdiction that has generated ordinary losses on a year-to-date basis or on the basis of the results anticipated for the full fiscal year and no benefit can be recognized on those losses, a separate effective tax rate should be computed and applied to ordinary income (or loss) in that jurisdiction. The Company incurred pretax loss during the three months ended March 31, 2014 from the Singapore operation and will not recognize tax benefit of the losses due to full valuation allowance established against deferred tax assets. Thus, separate effective tax rate was applied to losses from each loss jurisdiction to compute the Company’s interim tax expense. In addition, the discrete method was used to calculate the Company’s interim tax expense for the U.S. operations for the three months ended March 31, 2014. The Company has determined that a calculation of an annual effective tax rate would not represent a reliable estimate due to the sensitivity of the annual effective tax rate estimate to even minimal changes to forecasted earnings of the U.S. operations for the year. Under the discrete method, the Company determines its tax expense based upon actual results as if the interim period were an annual period.

The Company recorded an income tax expense of $527 and $3,476 in the three months ended March 31, 2014 and 2013, respectively. The effective tax rates were (113%) and (83%) in the three months ended March 31, 2014 and 2013, respectively. The difference between the effective tax rates and the 34% and 35% federal statutory rate in the three months ended March 31, 2014 and 2013, respectively, resulted primarily due to the change in valuation allowance, foreign income taxes provided at lower rates, geographic mix in expected operating results, unrecognized tax benefits, stock-based compensation adjustments and recognition of state research and development credits.

During the three months ended March 31, 2014, the gross amount of the Company’s unrecognized tax benefits increased approximately $556 as a result of tax positions taken during the current year. Substantially all of the unrecognized tax benefits as of March 31, 2014, if recognized, would affect the Company’s effective tax rate. The Company believes that in the next twelve months, it is reasonably possible that statute of limitation on income tax examination period will expire. Given the uncertainty, the Company can only determine a range of estimated potential decreases in underlying unrecognized tax benefits ranging from $0 to approximately $875.

The Company does not provide for U.S. income taxes on undistributed earnings of its controlled foreign corporations that are intended to be invested indefinitely outside the United States.

 

8


Table of Contents

Inphi Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

(Dollars in thousands except share and per share amounts)

 

9. Earnings Per Share

The following shows the computation of basic and diluted earnings per share:

 

     Three Months
Ended March 31,
 
     2014     2013  

Numerator

    

Net loss

   $ (995   $ (7,671
  

 

 

   

 

 

 

Denominator

    

Weighted average common stock

     30,699,590        28,943,810   

Less weighted average unvested restricted stock award

     (1,782     (10,705
  

 

 

   

 

 

 

Weighted average common stock—basic and diluted

     30,697,808        28,933,105   
  

 

 

   

 

 

 

Earnings per share

    

Basic

   $ (0.03   $ (0.27
  

 

 

   

 

 

 

Diluted

   $ (0.03   $ (0.27
  

 

 

   

 

 

 

The following securities were not included in the computation of diluted earnings per share as inclusion would have been anti-dilutive:

 

     Three Months
Ended March 31,
 
     2014      2013  

Common stock options

     3,760,969         4,623,434   

Restricted stock unit

     2,771,758         2,889,093   

Restricted stock award

     1,782         10,705   

Common stock warrant

     —           2,142   
  

 

 

    

 

 

 
     6,534,509         7,525,374   
  

 

 

    

 

 

 

10. Stock–Based Compensation

In 2000, the Company adopted the 2000 Stock Option/Stock Issuance Plan (the “2000 Plan”). Under the provisions of the 2000 Plan, employees, outside directors, consultants and other independent advisors who provide services to the Company may be issued incentive and non-qualified stock options to purchase common stock or may be issued shares of common stock directly. The Compensation Committee of the Board of Directors (the “Board”) is authorized to administer the 2000 Plan and establish the stock option terms, including the exercise price and vesting period. Options granted under the plan may have varying vesting schedules; however, options generally vest 25% upon completion of one year of service and thereafter in 36 equal monthly installments. Options granted are immediately exercisable and the shares issued upon exercise of the option are subject to a repurchase right held by the Company. The repurchase price under the repurchase right is the original exercise price and the right lapses in accordance with the option-vesting schedule. As of March 31, 2014 and December 31, 2013, there were no unvested shares outstanding subject to the Company’s right of repurchase. The vesting of certain options granted or shares issued under the 2000 Plan is subject to acceleration of vesting upon the occurrence of certain events as defined in the 2000 Plan.

Under the 2000 Plan, the exercise price, in the case of an incentive stock option, cannot be less than 100%, and in the case of a nonqualified stock option, not less than 85%, of the fair market value of such shares on the date of grant. The term of the option is determined by the Compensation Committee but in no case can exceed 10 years.

In June 2010, the Board approved the Company’s 2010 Stock Incentive Plan (the “2010 Plan”), which became effective in November 2010. The 2010 Plan provides for the grants of restricted stock, stock appreciation rights and stock unit awards to employees, non-employee directors, advisors and consultants. The Compensation Committee administers the 2010 Plan, including the determination of the recipient of an award, the number of shares subject to each award, whether an option is to be classified as an incentive stock option or nonstatutory option, and the terms and conditions of each award, including the exercise and purchase prices and the vesting or duration of the award. Options granted under the 2010 Plan are exercisable only upon vesting. At March 31, 2014, 3,266,912 shares of common stock have been reserved for future grants under the 2010 Plan.

 

9


Table of Contents

Inphi Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

(Dollars in thousands except share and per share amounts)

 

Stock Option Awards 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:

 

     Three Months Ended
March 31,
 
     2014      2013  

Risk-free interest rate

     —           1.30

Expected life (in years)

     —           6.25   

Dividend yield

     —           —     

Expected volatility

     —           50

The following table summarizes information regarding options outstanding:

 

     Number of
Shares
    Weighted
Average
Exercise
Price
     Weighted
Average
Remaining
Contractual
Life
     Aggregate
Intrinsic
Value
 

Outstanding at December 31, 2013

     3,883,097      $ 9.26         6.33       $ 16,229   
       

 

 

    

 

 

 

Granted

     —          —           

Exercised

     (369,280     3.33         

Canceled

     (44,071     10.25         
  

 

 

   

 

 

       

Outstanding at March 31, 2014

     3,469,746      $ 9.88         6.55       $ 22,158   
  

 

 

   

 

 

    

 

 

    

 

 

 

Exercisable at March 31, 2014

     2,378,360      $ 9.44         5.94       $ 17,450   
  

 

 

   

 

 

    

 

 

    

 

 

 

Vested at March 31, 2014

     2,263,552      $ 8.86         5.94       $ 16,715   
  

 

 

   

 

 

    

 

 

    

 

 

 

Vested and expected to vest at March 31, 2014

     3,447,063      $ 9.86         6.54       $ 22,055   
  

 

 

   

 

 

    

 

 

    

 

 

 

The intrinsic value of options outstanding, exercisable and vested and expected to vest is calculated based on the difference between the exercise price and the fair value of the Company’s common stock as of the respective balance sheet dates.

The weighted average grant date fair value per share of stock options granted to employees during the three months ended March 31, 2014 and 2013 was $0 and $4.37, respectively.

The total intrinsic value of options exercised during the three months ended March 31, 2014 and 2013 was $4,343 and $818, respectively. The intrinsic value of exercised options is calculated based on the difference between the exercise price and the fair value of the Company’s common stock as of the exercise date. Cash received from the exercise of stock options was $1,231 and $363 for the three months ended March 31, 2014 and 2013, respectively.

Restricted Stock Units and Awards

The Company granted restricted stock units (“RSUs”) to members of the Board and employees. Most of the Company’s outstanding RSUs vest over four years with vesting contingent upon continuous service. The Company estimates the fair value of RSUs using the market price of the common stock on the date of the grant. The fair value of these awards is amortized on a straight-line basis over the vesting period.

 

10


Table of Contents

Inphi Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

(Dollars in thousands except share and per share amounts)

 

The following table summarizes information regarding outstanding restricted stock units:

 

     Number of
Shares
    Weighted
Average
Grant Date Fair
Value Per Share
 

Outstanding at December 31, 2013

     3,209,567      $ 11.69   

Granted

     72,892        12.99   

Vested

     (584,076     11.32   

Canceled

     (84,217     11.42   
  

 

 

   

 

 

 

Outstanding at March 31, 2014

     2,614,166        11.82   
  

 

 

   

 

 

 

Expected to vest at March 31, 2014

     2,531,232     
  

 

 

   

The Company granted restricted stock awards (“RSAs”) to certain members of the Board. The Company estimates the fair value of RSAs using the market price of the common stock on the date of the grant. As of December 31, 2013, the Company had 2,851 outstanding unvested RSAs, 1,069 of which vested during the three months ended March 31, 2014 resulting to 1,782 unvested RSAs outstanding as of March 31, 2014.

Employee Stock Purchase Plan

In December 2011, the Company adopted the Employee Stock Purchase Plan (“ESPP”). Participants purchase the Company’s stock using payroll deductions, which may not exceed 15% of their total cash compensation. Pursuant to the terms of the ESPP, the “look-back” period for the stock purchase price is six months. Offering and purchase periods will begin on February 10 and August 10 of each year. Participants will be granted the right to purchase common stock at a price per share that is 85% of the lesser of the fair market value of the Company’s common shares at the beginning or the end of each six-month period.

The ESPP imposes certain limitations upon an employee’s right to acquire common stock, including the following: (i) no employee shall be granted a right to participate if such employee immediately after the election to purchase common stock, would own stock possessing 5% or more to the total combined voting power or value of all classes of stock of the Company, and (ii) no employee may be granted rights to purchase more than $25 fair value of common stock for each calendar year. The maximum aggregate number of shares of common stock available for purchase under the ESPP is one million shares. Total common stock issued under the ESPP during the three months ended March 31, 2014 and 2013 was 131,007 and 125,177, respectively.

The fair value of employee stock purchase plan is estimated at the start of offering period using the Black-Scholes option pricing model with the following assumptions:

 

     Three Months Ended
March 31,
 
     2014     2013  

Risk-free interest rate

     0.08     0.12

Expected life (in years)

     0.49        0.49   

Dividend yield

     —          —     

Expected volatility

     34     47

Estimated fair value

   $ 3.00      $ 2.63   

 

11


Table of Contents

Inphi Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

(Dollars in thousands except share and per share amounts)

 

Stock-Based Compensation Expense

Stock-based compensation expense is included in the Company’s results of operations as follows:

 

     Three Months
Ended March 31,
 
     2014      2013  

Operating expenses

     

Cost of goods sold

   $ 251       $ 233   

Research and development

     2,389         1,973   

Sales and marketing

     858         803   

General and administrative

     1,008         1,017   
  

 

 

    

 

 

 
   $ 4,506       $ 4,026   
  

 

 

    

 

 

 

Total unrecognized compensation cost related to unvested stock options at March 31, 2014, prior to the consideration of expected forfeitures, is approximately $31,168 and is expected to be recognized over a weighted-average period of 2.39 years.

11. Fair Value Measurements

The guidance on fair value measurements requires fair value measurements to be classified and disclosed in one of the following three categories:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability, or

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The Company measures its investments in marketable securities at fair value using the market approach, which uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The Company has cash equivalents which consist of money market funds valued using the amortized cost method, in accordance with Rule 2a-7 under the 1940 Act which approximates fair value.

The Company determines the amount of transfers between Levels 1 and 2 or transfers into or out of Level 3 by using the end-of-period fair value. The Company had no transfers among the fair value hierarchy during the three months ended March 31, 2014.

The following table presents information about assets required to be carried at fair value on a recurring basis:

 

March 31, 2014    Total      Level 1      Level 2  

Assets

        

Cash equivalents:

        

Money market funds

   $ 7,180       $ —         $ 7,180   

Investment in marketable securities:

        

U.S. treasury securities

     21,689         21,689         —     

Municipal bonds

     33,901         —           33,901   

Corporate notes/bonds

     31,635         —           31,635   

Certificate of deposit

     1,500         —           1,500   

Asset backed securities

     434         —           434   
  

 

 

    

 

 

    

 

 

 
   $ 96,339       $ 21,689       $ 74,650   
  

 

 

    

 

 

    

 

 

 

 

12


Table of Contents

Inphi Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

(Dollars in thousands except share and per share amounts)

 

December 31, 2013    Total      Level 1      Level 2  

Assets

        

Cash equivalents:

        

Money market funds

   $ 5,119       $ —         $ 5,119   

Investment in marketable securities:

        

U.S. treasury securities

     25,072         25,072         —     

Municipal bonds

     34,983         —           34,983   

Corporate notes/bonds

     28,648         —           28,648   

Certificate of deposit

     1,501         —           1,501   

Asset backed securities

     686         —           686   
  

 

 

    

 

 

    

 

 

 
   $ 96,009       $ 25,072       $ 70,937   
  

 

 

    

 

 

    

 

 

 

12. Segment and Geographic Information

The Company operates in one reportable segment. The Company’s Chief Executive Officer, who is considered to be the chief operating decision maker, manages the Company’s operations as a whole and reviews consolidated financial information for purposes of evaluating financial performance and allocating resources. Revenue by region is classified based on the locations to which the product is transported, which may differ from the customer’s principal offices.

The following table sets forth the Company’s revenue by geographic region:

 

     Three Months Ended
March 31,
 
     2014      2013  

China

   $ 12,515       $ 4,467   

United States

     5,459         5,430   

Korea

     2,107         5,689   

Other

     11,108         6,998   
  

 

 

    

 

 

 
   $ 31,189       $ 22,584   
  

 

 

    

 

 

 

As of March 31, 2014, $4,875 of long-lived tangible assets are located outside the United States, of which $4,455 are located in Taiwan. As of December 31, 2013, $5,217 of long-lived tangible assets are located outside the United States, of which $4,694 are located in Taiwan.

13. Commitments and Contingencies

Leases

The Company leases its facility and certain equipment under noncancelable lease agreements expiring in various years through 2018. The Company also licenses certain software used in its research and development activities under a term license subscription and maintenance arrangement.

 

13


Table of Contents

Inphi Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

(Dollars in thousands except share and per share amounts)

 

As of March 31, 2014, future minimum lease payments under noncancelable operating leases having initial terms in excess of one year are as follows:

 

2014 (remaining)

   $ 4,850   

2015

     6,497   

2016

     3,327   

2017

     1,909   

2018

     188   
  

 

 

 
   $ 16,771   
  

 

 

 

For the three months ended March 31, 2014 and 2013, lease operating expense was $1,423 and $1,664, respectively.

Noncancelable Purchase Obligations

The Company’s noncancelable purchase obligations consisted primarily of license fees the Company committed to pay under several agreements. As of March 31, 2014, the Company’s future total noncancelable purchase obligations was $127 which are all payable in 2014.

We depend upon third party subcontractors to manufacture our wafers. Our subcontractor relationships typically allow for the cancellation of outstanding purchase orders, but require payment of all expenses incurred through the date of cancellation. As of March 31, 2014, the total value of open purchase orders for wafers was approximately $2,765.

Legal Proceedings

Netlist, Inc. v. Inphi Corporation, Case No. 09-cv-6900 (C.D. Cal.)

On September 22, 2009, Netlist filed suit in the United States District Court, Central District of California, or the Court, asserting that the Company infringes U.S. Patent No. 7,532,537. Netlist filed an amended complaint on December 22, 2009, further asserting that the Company infringes U.S. Patent Nos. 7,619,912 and 7,636,274, collectively with U.S. Patent No. 7,532,537, the patents-in-suit, and seeking both unspecified monetary damages to be determined and an injunction to prevent further infringement. These infringement claims allege that the Company’s iMB™ and certain other memory module components infringe the patents-in-suit. The Company answered the amended complaint on February 11, 2010 and asserted that the Company does not infringe the patents-in-suit and that the patents-in-suit are invalid. In 2010, Company filed inter partes requests for reexamination with the United States Patent and Trademark Office (the “USPTO”), asserting that the patents-in-suit are invalid.

On August 27, 2010, the USPTO ordered the request for Inter Partes Reexamination for U.S. Patent No. 7,636,274 and found a substantial new question of patentability based upon each of the different issues that the Company raised as the reexamination requestor. On September 27, 2011, the Patent Office issued a First Office Action based on the Netlist ‘274 Patent Reexamination Request and rejected 91 of its 97 claims. On October 27, 2011, Netlist responded to the USPTO determination by amending some but not all of the claims, adding new claims and making arguments as to the validity of the rejected claims in view of the cited references. The Company provided rebuttable comments to the USPTO on November 28, 2011. On March 12, 2012, the Examiner issued an Action Closing Prosecution, indicating that the claims pending contain allowable subject matter, and Netlist did not respond to the Action Closing Prosecution in the time provided by the USPTO. On June 22, 2012, the USPTO issued a Right of Appeal Notice, and on July 23, 2012, the Company filed a Notice of Appeal. The Company filed its Appeal Brief on September 24, 2012 and Netlist filed its Responsive Brief on October 24, 2012. The parties received an Examiner’s Answer dated April 16, 2013 from the USPTO that maintained the rejections set forth on the Right of Appeal Notice dated June 22, 2012. The Company filed a Rebuttal Brief on May 16, 2013 and a Request for Oral Hearing on June 7, 2013. The appeal hearing took place on November 20, 2013. The Patent Trial and Appeal Board (PTAB) issued its decision on January 16, 2014, finding the Examiner erred in declining to adopt 8 of the 9 different rejections that had been proposed by the Company. The Company requested a rehearing of the decision not to adopt the remaining one rejection that had been proposed by Company and was not adopted by the PTAB on February 18, 2014. In papers dated March 18, 2014, Netlist provided rebuttal comments to the request for rehearing and also requested re-opening of prosecution with respect to the claims that the PTAB had rejected, and in that request to re-open prosecution amended the independent claims that stood rejected. The Company filed comments with respect to these proposed amended claims on April 17, 2014. A communication from the USPTO is expected as the next substantive step of the proceeding, as prosecution otherwise remains closed. The proceeding is expected to continue in accordance with established Inter Partes Reexamination procedures.

 

14


Table of Contents

Inphi Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

(Dollars in thousands except share and per share amounts)

 

On September 8, 2010, the USPTO ordered the request for Inter Partes Reexamination for U.S. Patent No. 7,532,537 and found a substantial new question of patentability based upon different issues that the Company raised as the reexamination requestor. The USPTO accompanied this Reexamination Order of U.S. Patent No. 7,532,537 with its own evaluation of the validity of this patent, and rejected some but not all of claims. In a response dated October 8, 2010, Netlist responded to the USPTO determination by amending some but not all of the claims, adding new claims and making arguments as to why the claims were not invalid in view of the cited references. The Company provided rebuttable comments to the USPTO on November 8, 2010 along with a Petition requesting an increase in the number of allowed pages of the rebuttable comments. On January 20, 2011, the USPTO granted the Petition in part. The Company then filed updated rebuttal comments on January 27, 2011 in compliance with the granted Petition. The USPTO has considered these updated rebuttal comments, and in a communication dated June 15, 2011, continued to reject all the previously rejected claims. The USPTO also rejected all the claims newly added in the October 8, 2010 Netlist response. In a further communication dated June 21, 2011, the USPTO issued an Action Closing Prosecution indicating that it would confirm the patentability of four claims and reject all the other pending claims. On August 22, 2011, Netlist responded to the Action Closing Prosecution by further amending some claims and making arguments as to the validity of the rejected claims in view of the cited references. The Company submitted rebuttal comments on September 21, 2011. In a further communication dated February 7, 2012, the USPTO issued a Right of Appeal Notice, which also indicated that the previous amendments to claim made by Netlist would be entered, and that the current pending claims, as amended, were patentable. The Company filed a Notice of Appeal at the USPTO on March 8, 2012, within the time period provided for filing the Notice of Appeal and Netlist did not file Notice of Cross-Appeal. The Company filed its Appeal Brief on May 8, 2012, and Netlist filed its Responsive Brief on July 2, 2012. The parties received an Examiner’s Answer dated April 16, 2013 from the USPTO that maintained the rejections set forth on the Right of Appeal Notice dated February 7, 2012. The Company filed a Rebuttal Brief on May 16, 2013 and a Request for Oral Hearing on June 7, 2013. The appeal hearing took place in front of the PTAB on November 20, 2013. The PTAB issued its decision on January 16, 2014, affirming the Examiner’s decision as to all of the challenged claims. On February 18, 2014, the Company made a request for rehearing of the decision, and in papers dated March 18, 2014, Netlist provided rebuttal comments to the request for rehearing. A communication from the PTAB is expected as the next substantive step of the proceeding, as prosecution otherwise remains closed. The proceeding is expected to continue in accordance with established Inter Partes Reexamination procedures.

On September 8, 2010, the USPTO ordered the request for Inter Partes Reexamination for U.S. Patent No. 7,619,912 and found a substantial new question of patentability based upon different issues that the Company raised as the reexamination requestor. The USPTO accompanied this Reexamination Order of U.S. Patent No. 7,619,912 with its own evaluation of the validity of this patent, and initially determined that all of the claims were patentable based upon the Company’s request for Inter Partes Reexamination. Netlist did not comment upon this Reexamination Order. The USPTO on February 28, 2011 also merged the Proceedings of the Company’s Reexamination of U.S. Patent No. 7,619,912, bearing Control No. 90/001,339 with Inter Partes Reexamination Proceeding 95/000,578 filed October 20, 2010 on behalf of SMART Modular Technologies, Inc. and Inter Partes Reexamination Proceeding 95/000,579 filed October 21, 2010 on behalf of Google, Inc. In each of these other Reexamination Proceedings, the USPTO had indicated that there existed a substantial new question of patentability with respect to certain claims of U.S. Patent No. 7,619,912, but had not accompanied the Reexamination Orders related thereto with its own evaluation of the validity of this patent, indicating that such evaluation would be forthcoming at a later time. This further evaluation was received in an Office Action dated April 4, 2011, in which the Examiner rejected a substantial majority of the claims based upon a number of different rejections, including certain of the rejections originally proposed by the Company in its Request for Reexamination. This Office Action also indicated that one claim was deemed to be patentable over the prior art of record in the merged Reexamination Proceedings. After seeking and obtaining an extension of time to respond to the Office Action dated April 4, 2011, Netlist served its response on July 5, 2011, which added new claims and made arguments as to why the originally filed claims were not invalid in view of the cited references. Each of the merged Reexamination Requestors, including the Company, submitted rebuttal comments by August 29, 2011. The USPTO considered this Netlist response and each of the rebuttal comments, and in an Office Action dated October 14, 2011, continued to reject most, but not all of the previously rejected claims, as well as rejected claims that had been added by Netlist in its July 5, 2011 response. After seeking and obtaining an extension of time to respond to the Office Action dated October 14, 2011, Netlist served its response on January 13, 2012, which response made amendments based upon subject matter that had been indicated as allowable in the Office Action dated October 14, 2011, added other new claims and made arguments as to why all of these claims should be allowed. The three different merged Reexamination Requestors, including the Company, timely submitted rebuttal comments on or about February 13, 2012. The USPTO issued a Non-final Office Action on November 13, 2012, rejecting some claims and indicating that others contained allowable subject matter. On January 14, 2013, Netlist filed a Response to the Non-final Office Action which presented further claim amendments and evidence supporting its positions regarding patentability. Rebuttal comments from the Company and the other Requestors were filed on February 13, 2013. On March 21, 2014, the USPTO issued an Action Closing Prosecution in which the USPTO indicated that certain of the pending claims were allowable and other of the pending claims were rejected. A communication from Netlist is permitted as the next substantive step of the proceeding, as prosecution otherwise remains closed. The merged proceeding is expected to continue in accordance with established Inter Partes Reexamination procedures.

 

15


Table of Contents

Inphi Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

(Dollars in thousands except share and per share amounts)

 

The reexamination proceedings could result in a determination that the patents-in-suit, in whole or in part, are valid or invalid, as well as modifications of the scope of the patents-in-suit.

Based on these papers the Court in January 2014 ordered a continued stay of the proceedings, took the litigation off the active court calendar, and requested that the parties file a joint status report on May 1, 2014 and every 120 days thereafter advising the Court as to status of the reexamination proceedings at which times, the Court could decide to maintain or lift the stay.

While the Company intends to defend the foregoing lawsuit vigorously, litigation, whether or not determined in the Company’s favor or settled, could be costly and time-consuming and could divert management’s attention and resources, which could adversely affect the Company’s business.

Based on the nature of the litigation, the Company is currently unable to predict the final outcome of this lawsuit and therefore, cannot determine the likelihood of loss nor estimate a range of possible loss. However, because of the nature and inherent uncertainties of litigation, should the outcome of these actions be unfavorable, the Company’s business, financial condition, results of operations or cash flows could be materially and adversely affected.

Indemnifications

In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, investors, directors, officers, employees and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third-parties. These indemnifications may survive termination of the underlying agreement and the maximum potential amount of future payments the Company could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnifications. Accordingly, the Company has no liabilities recorded for these agreements as of March 31, 2014 and December 31, 2013.

14. Subsequent Events

In April 2014, the Compensation Committee granted 1,338,648 restricted stock units to employees and consultants.

 

16


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and notes to those statements included elsewhere in this Report. This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this report, the terms “may,” “might,” “will,” “objective,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “estimate,” “predict,” “potential,” “plan,” or the negative of these terms, and similar expressions intended to identify forward-looking statements. These statements relate to future periods and include statements regarding our anticipated trends and challenges in our business and the markets in which we operate, including the market for 100G high-speed analog semiconductor solutions, our plans for future products, such as our isolation memory buffer, or iMB™, clock and data recovery, or CDR, complementary metal oxide semiconductor, or CMOS, and serializer/deserializer, or SerDes, products, our transimpedance amplifier, or TIA products, our quad linear driver products, expansion of our product offerings and enhancements of existing products, our expectations regarding our expenses and revenue, our tax benefits, the benefits of our products and services, timing of the development of our products, our anticipated cash needs and our estimates regarding our capital requirements and our needs for additional financing, repatriation of cash, our anticipated growth and growth strategies, interest rate sensitivity, adequacy of our disclosure controls, customer concentration, foundry constraints, competition, protection of our intellectual property, our dividend policy and our legal proceedings. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these or any other forward-looking statements. These risks and uncertainties include, but are not limited to, those risks discussed below, as well as factors affecting our results of operations, our ability to manage our growth, our ability to sustain or increase profitability, demand for our solutions, the effect of declines in average selling prices for our products, our ability to compete, our ability to rapidly develop new technology and introduce new products, our ability to safeguard our intellectual property, trends in the semiconductor industry and fluctuations in general economic conditions, and the risks set forth throughout this Report, including the risks set forth under Part II, “ Item 1A, Risk Factors”. Readers are cautioned not to place undue reliance on these forward-looking statements, which are based on current expectations and reflect management’s opinions only as of the date hereof. These forward-looking statements speak only as of the date of this Report. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any changes in events, conditions or circumstances on which any such statement is based.

All references to “Inphi,” “we,” “us” or “our” mean Inphi Corporation.

Inphi®, iMB™, iKON and the Inphi logo are trademarks or service marks owned by Inphi. All other trademarks, service marks and trade names appearing in this report are the property of their respective owners.

Overview

Our Company

We are a fabless provider of high-speed analog and mixed signal semiconductor solutions for the communications, data center and computing markets. Our semiconductor solutions provide high signal integrity at leading-edge data speeds while reducing system power consumption. Our semiconductor solutions are designed to address bandwidth bottlenecks in networks, maximize throughput and minimize latency in computing environments and enable the rollout of next generation communications, data center and computing infrastructures. Our solutions provide a vital high-speed interface between analog signals and digital information in high-performance systems such as telecommunications transport systems, enterprise networking equipment, data centers and enterprise servers, storage platforms, test and measurement equipment and military systems. We provide 100G high-speed analog semiconductor solutions for the communications market and high-speed memory interface solutions for the computing market.

We have a product portfolio with many products sold in communication and data center markets as of March 31, 2014, including our 100 GbE CMOS SerDes architecture, or iPHY, which is designed to enable the development of next generation low power and high port density 100 Gigabit Ethernet, or 100 GbE, solutions to address bandwidth bottlenecks in next generation data center and communications infrastructures.

In the first quarter of 2014, we started sampling the IN3252TA, the industry’s first 32 Gbps dual high gain linear/variable-gain amplifier. The IN3252TA is designed specifically to address the demanding requirements for 100G coherent transmission for the Metro market. We also announced the availability of a new iKON™ family of 100G Clock and Data Recovery Retimer integrated circuits (IC) targeted at next-generation 2-Terabit line cards. The first product in this series, the IN112525-LC 100G CMOS CDR Retimer IC, is for 28G line cards that will be architected with CFP4 and QSFP28 modules to accelerate deployment for higher density 100G in data center and enterprise networks.

 

17


Table of Contents

A detailed discussion of our business may be found in Part I, Item 1, “Business,” of our 2013 Annual Report on Form 10-K.

Quarterly Update

As discussed in more detail below, for the three months ended March 31, 2014 compared to the three months ended March 31, 2013, we delivered the following financial performance:

 

    Total revenues increased by $8.6 million, or 38%, to $31.2 million.

 

    Gross profit as a percentage of revenue increased from 63% to 65%.

 

    Total operating expenses increased by $2.1 million, or 11%, to $20.8 million.

 

    Loss from operations decreased by $3.8 million, or 86%, to a loss of $0.6 million.

 

    Diluted loss per share decreased by $0.24, to $(0.03).

The increase in our revenue was a result of increase in consumption of our iMB, dual linear TIA and quad linear driver products.

Total operating expenses increased due primarily to an increase in headcount and stock-based compensation expense. Our expenses primarily consist of personnel costs, which include compensation, benefits, payroll related taxes and stock-based compensation. From April 2013 to March 2014, we hired 69 new employees, primarily in the engineering department. We expect expenses to continue to increase in absolute dollars as we continue to invest resources to develop more products and to support the growth of our business. Our diluted loss per share decreased primarily due to increase in revenue and decrease in provision for income taxes.

Our cash and cash equivalents were $27.8 million at March 31, 2014, compared with $31.7 million at December 31, 2013. Cash used in operations of $2.1 million during the three months ended March 31, 2014 compared to cash generated from operating activities of $1.1 million during the three months ended March 31, 2013. The change was mainly due to shipments made in March 2014 which will be collected in the second quarter of 2014. Cash used in investing activities during the three months ended March 31, 2014 was $1.6 million primarily due to purchases of marketable securities and purchases of property and equipment of $19.9 million offset by sales and maturities of marketable securities of $18.2 million. Cash used in financing activities of $67 thousand was primarily due to minimum tax withholding paid on behalf of employees of $2.6 million offset by proceeds from exercise of stock options and employee stock purchase plan of $2.5 million.

Critical Accounting Policies and Estimates

The preparation of financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses in the reporting period. We regularly evaluate our estimates and assumptions related to allowances for doubtful accounts, warranty reserves, inventory reserves, stock-based compensation expense, goodwill valuation, deferred income tax asset valuation allowances, uncertain tax positions, litigation and other loss contingencies. We base our estimates and assumptions on current facts, historical experience and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of revenue, costs and expenses that are not readily apparent from other sources. The actual results experienced by us may differ materially and adversely from our estimates. To the extent there are material differences between our estimates and the actual results, our future results of operations will be affected. For a description of our critical accounting policies and estimates, please refer to the “Critical Accounting Policies and Estimates” section of our Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the year ended December 31, 2013. There have been no material changes in any of our critical accounting policies during the three months ended March 31, 2014.

 

18


Table of Contents

Results of Operations

The following table sets forth a summary of our statement of operations as a percentage of each line item to the revenue:

 

     Three Months
Ended March 31,
 
     2014     2013  

Total revenue

     100     100

Cost of revenue

     35        37   
  

 

 

   

 

 

 

Gross profit

     65        63   
  

 

 

   

 

 

 

Operating expense:

    

Research and development

     44        51   

Sales and marketing

     13        18   

General and administrative

     10        14   
  

 

 

   

 

 

 

Total operating expenses

     67        83   
  

 

 

   

 

 

 

Loss from operations

     (2     (20

Other income

     1        1   
  

 

 

   

 

 

 

Loss before income taxes

     (1     (19

Provision for income taxes

     2        15   
  

 

 

   

 

 

 

Net loss

     (3 )%      (34 )% 
  

 

 

   

 

 

 

Comparison of Three Months Ended March 31, 2014 and 2013

Revenue

 

     Three Months Ended March 31,      Change  
     2014      2013      Amount      %  
     (dollars in thousands)  

Revenue

   $ 31,189       $ 22,584       $ 8,605         38

Total revenue for the three months ended March 31, 2014 increased by $8.6 million primarily due to an increase of 50% in the average selling price of our products, partially offset by a decrease in the number of units sold of 8%. The increase in average selling price was due to change in product mix that resulted in an increase in sales of our higher priced products which includes iMB, dual linear TIA and quad linear driver products. The decrease in number of units sold was due to lower consumption of our high speed memory interface products.

Cost of Revenue and Gross Profit

 

     Three Months Ended March 31,     Change  
     2014     2013     Amount      %  
     (dollars in thousands)  

Cost of revenue

   $ 11,063      $ 8,292      $ 2,771         33

Gross profit

   $ 20,126      $ 14,292      $ 5,834         41

Gross profit as a percentage of revenue

     65     63     —           2

Cost of revenue for the three months ended March 31, 2014 increased by $2.8 million primarily due to increases in revenue as described above. Gross profit as a percentage of revenue increased by 2% due to sales of higher margin products as described above.

Research and Development

 

     Three Months Ended March 31,      Change  
     2014      2013      Amount      %  
     (dollars in thousands)  

Research and development

   $ 13,739       $ 11,598       $ 2,141         18

Research and development expense for the three months ended March 31, 2014 increased by $2.1 million due to the increase in research and development headcount and equity awards, which resulted in a $2.0 million increase in personnel costs and stock-based compensation expense. In addition, consulting expense increased by $0.1 million to provide engineering support. CAD software tool license expense increased by $0.1 million due to increase in headcount. The increases were partially offset by reimbursement from customer related to research and development contract of $0.5 million. The increase in research and development expense was primarily driven by our strategy to expand our product offerings and enhance our existing products.

 

19


Table of Contents

Sales and Marketing

 

     Three Months Ended March 31,      Change  
     2014      2013      Amount      %  
     (dollars in thousands)  

Sales and marketing

   $ 3,950       $ 3,947       $ 3         —     

Sales and marketing expense for the three months ended March 31, 2014 slightly increased primarily due to increase in personnel costs, including stock-based compensation expense of $0.1 million offset by decrease in commission expense by $0.1 million due to higher direct sales and lower commission fees.

General and Administrative

 

     Three Months Ended March 31,      Change  
     2014      2013      Amount     %  
     (dollars in thousands)  

General and administrative

   $ 3,065       $ 3,155       ($ 90     (3 %) 

General and administrative expenses for the three months ended March 31, 2014 decreased by $0.1 million. The decrease was due to rent on a vacant building and related expense of $0.2 million incurred in the three months ended March 31, 2013, partially offset by $0.1 million of increase in personnel cost due to new hires.

Provision for Income Tax

 

     Three Months Ended March 31,      Change  
     2014      2013      Amount     %  
     (dollars in thousands)  

Provision for income tax

   $ 527       $ 3,476       ($ 2,949     (85 %) 

We normally determine our interim provision using an estimated single annual effective tax rate for all tax jurisdictions. ASC 740 provides that when an entity operates in a jurisdiction that has generated ordinary losses on a year-to-date basis or on the basis of the results anticipated for the full fiscal year and no benefit can be recognized on those losses, a separate effective tax rate should be computed and applied to ordinary income (or loss) in that jurisdiction. We incurred pretax loss during the three months ended March 31, 2014 from the Singapore operations and will not recognize tax benefit of the losses due to full valuation allowance established against deferred tax assets. Thus, separate effective tax rate was applied to losses from each loss jurisdiction to compute the interim tax expense. In addition, the discrete method was used to calculate the interim tax expense for U.S. operations for the three months ended March 31, 2014. We determined that a calculation of an annual effective tax rate would not represent a reliable estimate due to the sensitivity of the annual effective tax rate estimate to even minimal changes to forecasted earnings of the U.S. operations for the year. Under the discrete method, we determine the tax expense based upon actual results as if the interim period were an annual period.

The income tax expense of $0.5 million for the three months ended March 31, 2014 reflects an effective tax rate of (113%). This effective tax rate for the three months ended March 31, 2014 differed from the statutory rate of 34% primarily due to the change in valuation allowance, foreign income taxes provided at lower rates, geographic mix in operating results, unrecognized tax benefits and recognition of state research and development credits.

The income tax expense of $3.5 million for the three months ended March 31, 2013 reflects an effective tax rate of (83%). This effective tax rate for the three months ended March 31, 2013 differed from the statutory rate of 35% primarily due to the change in valuation allowance (originally established in the fourth quarter of 2012), foreign income taxes provided at lower rates, geographic mix in profitability, unrecognized tax benefits and stock-based compensation adjustments.

 

20


Table of Contents

Liquidity and Capital Resources

As of March 31, 2014, we had cash, cash equivalents and investments in marketable securities of $117.0 million. Our primary uses of cash are to fund operating expenses, purchase inventory and acquire property and equipment. Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the changes in our outstanding accounts payable and accrued expenses. Our primary sources of cash are cash receipts on accounts receivable from our revenue. Aside from the growth in amounts billed to our customers, net cash collections of accounts receivable are impacted by the efficiency of our cash collections process, which can vary from period to period, depending on the payment cycles of our major customers.

The following table summarizes our cash flows for the periods indicated:

 

     Three Months
Ended March 31,
 
     2014     2013  
     (in thousands)  

Net cash provided by (used in) operating activities

   $ (2,128   $ 1,097   

Net cash used in investing activities

     (1,638     (4,362

Net cash provided by (used in) financing activities

     (67     2,840   
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

   $ (3,833   $ (425
  

 

 

   

 

 

 

Net Cash Provided by (Used in) Operating Activities

Net cash used in operating activities during the three months ended March 31, 2014 primarily reflected increases in accounts receivable of $5.0 million and prepaid expenses and other assets of $1.8 million, decrease in accrued expenses of $1.3 million and net loss of $1.0 million partially offset by depreciation and amortization of $2.4 million and stock-based compensation of $4.5 million. Our receivables increased due to shipments made in the last month of the quarter. Our prepaid expenses increased as a result of new subscriptions. Our accrued expenses decreased as a result of payment of employee related costs.

Net cash provided by operating activities during the three months ended March 31, 2013 primarily reflected a decrease in accounts receivable of $1.8 million, increase in deferred revenue of $0.3 million, change in income tax payable/receivable of $2.9 million, depreciation and amortization of $1.7 million, deferred income taxes and deferred tax charge of $0.7 million and stock-based compensation of $4.0 million partially offset by net loss of $7.7 million, decrease in accrued expenses of $1.1 million and excess tax benefit related to stock-based compensation of $2.0 million. Our accounts receivable decreased due to collections. Our deferred revenue increased due to shipment to distributors to meet the demands of end customers in the second quarter. Our accrued expenses decreased as a result of payment of employee related costs.

Net Cash Used in Investing Activities

Net cash used in investing activities during the three months ended March 31, 2014, consisted of cash used to purchase property and equipment of $3.2 million and purchases of marketable securities of $16.7 million, offset by sales and maturities of marketable securities of $18.2 million.

Net cash used in investing activities during the three months ended March 31, 2013, consisted of cash used to purchase property and equipment of $3.7 million and purchases of marketable securities of $11.2 million, offset by sales and maturities of marketable securities of $10.6 million.

Net Cash Provided by (Used in) Financing Activities

Net cash provided by financing activities during the three months ended March 31, 2014 consisted of proceeds from exercise of stock options and employee stock purchase plan of $2.5 million, offset by minimum tax withholding paid on behalf of employees for restricted stock units of $2.6 million.

Net cash provided by financing activities during the three months ended March 31, 2013 consisted of proceeds from exercise of stock options and employee stock purchase plan of $1.4 million and excess tax benefit related to stock-based compensation of $2.0 million, offset by minimum tax withholding paid on behalf of employees for restricted stock units of $0.5 million.

 

21


Table of Contents

Operating and Capital Expenditure Requirements

Our principal source of liquidity as of March 31, 2014 consisted of $117.0 million of cash, cash equivalents and investments in marketable securities, of which $6.9 million is held by our foreign subsidiaries. Based on our current operating plan, we believe that our existing cash and cash equivalents from operations will be sufficient to finance our operational cash needs through at least the next 12 to 18 months. In the future, we expect our operating and capital expenditures to increase as we increase headcount, expand our business activities and grow our end customer base which will result in higher needs for working capital. Our ability to generate cash from operations is also subject to substantial risks described in Part II, Item 1A, Risk Factors. If any of these risks occur, we may be unable to generate or sustain positive cash flow from operating activities. We would then be required to use existing cash and cash equivalents to support our working capital and other cash requirements. If additional funds are required to support our working capital requirements, acquisitions or other purposes, we may seek to raise funds through debt financing or from other sources. If we raise additional funds through the issuance of equity or convertible debt securities, the percentage ownership of our stockholders could be significantly diluted, and these newly-issued securities may have rights, preferences or privileges senior to those of existing stockholders. If we raise additional funds by obtaining loans from third parties, the terms of those financing arrangements may include negative covenants or other restrictions on our business that could impair our operating flexibility, and would also require us to incur interest expense. We can provide no assurance that additional financing will be available at all or, if available, that we would be able to obtain additional financing on terms favorable to us.

We do not plan to repatriate cash balances from foreign subsidiaries to fund our operations in the United States. There may be adverse tax effects upon repatriation of these funds to the United States.

Recent Authoritative Accounting Guidance

See note 2 of the notes to our unaudited condensed consolidated financial statements for information regarding recently issued accounting pronouncements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Sensitivity

We had cash and cash equivalents and investments in marketable securities of $117.0 million and $122.6 million at March 31, 2014 and December 31, 2013, respectively, which was held for working capital purposes. Our exposure to market interest-rate risk relates primarily to our investment portfolio. We do not use derivative financial instruments to hedge the market risks of our investments. We manage our total portfolio to encompass a diversified pool of investment-grade securities to preserve principal and maintain liquidity. We place our investments with high-quality issuers, money market funds and debt securities. Our investment portfolio as of March 31, 2014 consisted of money market funds, U.S. Treasuries, municipal bonds, corporate bonds, certificates of deposit, and asset backed securities. Investments in both fixed rate and floating rate instruments carry a degree of interest rate risk. Fixed rate securities may have their market value adversely impacted due to an increase in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may fall short of expectations due to changes in interest rates or if the decline in fair value of our publicly traded debt investments is judged to be other-than-temporary. We may suffer losses in principal if we are forced to sell securities that have declined in market value due to changes in interest rates. However, because any debt securities we hold are classified as available-for-sale, no gains or losses are realized in the income statement due to changes in interest rates unless such securities are sold prior to maturity or unless declines in value are determined to be other-than-temporary. These securities are reported at fair value with the related unrealized gains and losses, net of applicable taxes, included in accumulated other comprehensive income (loss), reported in a separate component of stockholders’ equity. Although, we currently expect that our ability to access or liquidate these investments as needed to support our business activities will continue, we cannot ensure that this will not change.

In a low interest rate environment, as short-term investments mature, reinvestment may occur at less favorable market rates. Given the short-term nature of certain investments, the current interest rate environment may negatively impact our investment income.

Foreign Currency Risk

To date, our international customer and vendor agreements have been denominated almost exclusively in United States dollars. Accordingly, we have limited exposure to foreign currency exchange rates and do not currently enter into foreign currency hedging transactions.

 

22


Table of Contents
Item 4. Controls and Procedures

Evaluation of disclosure controls and procedures

We maintain “disclosure controls and procedures,” as such term is defined in Rule 13a-15 (e) under the Securities Exchange Act 1934, or the Exchange Act, that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures met. Our disclosure controls and procedures have been designed to meet reasonable assurance standards. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Based on their evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

The information required by this Item 1 is set forth under Note 13 of Notes to Unaudited Condensed Consolidated Financial Statements, included in Part I, Item 1 of this Report, and is hereby incorporated by reference herein. For an additional discussion of certain risks associated with legal proceedings, see Item 1A, Risk Factors below.

Item 1A. Risk Factors

You should carefully consider the risks described in Part I, Item 1A, Risk Factors, of our Annual Report on Form 10-K for the year ended December 31, 2013, which are incorporated by reference herein, as our business, financial condition and results of operations could be adversely affected by any of the risks and uncertainties described therein. There have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2013.

 

23


Table of Contents

Item 6. Exhibits

(a) Exhibits. The following Exhibits are attached hereto and incorporated herein by reference:

 

Exhibit
Number

 

Description

    3(i)   Restated Certificate of Incorporation of the Registrant (incorporated by reference to exhibit 3(i) of the Registrant’s annual report on Form 10-K filed with the SEC on March 7, 2011).
    3(ii)   Amended and Restated Bylaws of the Registrant (incorporated by reference to exhibit 3(ii).2 filed with Registration Statement on Form S-1 (File No. 333-167564)).
    4.1   Specimen Common Stock Certificate (incorporated by reference to exhibit 4.1 filed with Registration Statement on Form S-1 (File No. 333-167564).
    4.2   Amended and Restated Investors’ Rights Agreement dated as of August 12, 2010 (incorporated by reference to exhibit 4.2 of the Registrant’s annual report on Form 10-K filed with the SEC on March 7, 2011).
  31.1   Certificate of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
  31.2   Certificate of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
  32.1(1)   Certificate of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
  32.2(1)   Certificate of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema
101.CAL   XBRL Taxonomy Extension Calculation Linkbase
101.DEF   XBRL Taxonomy Extension Definition Linkbase
101.LAB   XBRL Taxonomy Extension Label Linkbase
101.PRE   XBRL Taxonomy Extension Presentation Linkbase

 

(1) The material contained in Exhibit 32.1 and Exhibit 32.2 is not deemed “filed” with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language contained in such filing, except to the extent that the registrant specifically incorporates it by reference.

 

24


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

INPHI CORPORATION,
(Registrant)

/s/ Ford Tamer

Ford Tamer
Chief Executive Officer
(Principal Executive Officer)

May 7, 2014

 

25


Table of Contents

EXHIBIT INDEX

 

Number

 

Description

    3(i)   Restated Certificate of Incorporation of the Registrant (incorporated by reference to exhibit 3(i) of the Registrant’s annual report on Form 10-K filed with the SEC on March 7, 2011).
    3(ii)   Amended and Restated Bylaws of the Registrant (incorporated by reference to exhibit 3(ii).2 filed with Registration Statement on Form S-1 (File No. 333-167564)).
    4.1   Specimen Common Stock Certificate (incorporated by reference to exhibit 4.1 filed with Registration Statement on Form S-1 (File No. 333-167564).
    4.2   Amended and Restated Investors’ Rights Agreement dated as of August 12, 2010 (incorporated by reference to exhibit 4.2 of the Registrant’s annual report on Form 10-K filed with the SEC on March 7, 2011).
  31.1   Certificate of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
  31.2   Certificate of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
  32.1(1)   Certificate of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
  32.2(1)   Certificate of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema
101.CAL   XBRL Taxonomy Extension Calculation Linkbase
101.DEF   XBRL Taxonomy Extension Definition Linkbase
101.LAB   XBRL Taxonomy Extension Label Linkbase
101.PRE   XBRL Taxonomy Extension Presentation Linkbase

 

(1) The material contained in Exhibit 32.1 and Exhibit 32.2 is not deemed “filed” with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language contained in such filing, except to the extent that the registrant specifically incorporates it by reference.

 

26